Literature DB >> 1982564

Effects of drug administration in pregnancy on children's school behaviour.

L Stika1, K Elisová, L Honzáková, H Hrochová, H Plechatová, J Strnadová, B Skop, J Svihovec, M Váchova, O Vinar.   

Abstract

Files with prescription data were used to assess possible behavioural changes in children, whose mothers used benzodiazepines or neuroleptic drugs during the second half of their pregnancy. Prescriptions, bearing the identification number of women resident in one district of Prague, filed in pharmacies during 1974 and the first three months of 1975 represent the first part of the data. During 1984, children born in the appropriate earlier period were searched and linked with the earlier prescription data. A group of 68 children with possible exposure to neuroleptics and a group of 15 children possibly exposed to diazepam during the second half of their intrauterine development were found. Two groups of 55 and 7 children, respectively, born of mothers without exposure to these drugs, were chosen as controls. The teachers of classes attended by these children were addressed by a letter and asked to evaluate their behaviour at school. This was done by means of a form containing analogue scales evaluating different features of behaviour. Each child was compared with its control. The statistical evaluation with Student's t-test, regression analysis and analysis of variance did not reveal any significant difference between both groups and their controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982564     DOI: 10.1007/bf01967827

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  18 in total

1.  Recording of drug prescriptions in the county of Jämtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy.

Authors:  G Boethius
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

2.  Drug prescribing during pregnancy. A controlled study of Tennessee Medicaid recipients.

Authors:  J C Brocklebank; W A Ray; C F Federspiel; W Schaffner
Journal:  Am J Obstet Gynecol       Date:  1978-10-01       Impact factor: 8.661

3.  Automated processing of medical prescriptions.

Authors:  L Stika; M Hovorová; J Kratochvíl
Journal:  Act Nerv Super (Praha)       Date:  1971

4.  Benzodiazepine overconsumption in pregnancy.

Authors:  L Laegreid; R Olegård; J Wahlström; N Conradi; L Sisfontes
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

5.  Exposure to benzodiazepines in utero.

Authors:  W S Barry; S M St Clair
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

6.  Psychotropics during pregnancy and lactation: a review.

Authors:  J R Calabrese; A D Gulledge
Journal:  Psychosomatics       Date:  1985-05       Impact factor: 2.386

7.  A prospective study of drugs and pregnancy. I. Psychopharmaca.

Authors:  S Kullander; B Källén
Journal:  Acta Obstet Gynecol Scand       Date:  1976       Impact factor: 3.636

8.  Associations between drugs administered during pregnancy and congenital abnormalities of the fetus.

Authors:  M M Nelson; J O Forfar
Journal:  Br Med J       Date:  1971-03-06

9.  Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring.

Authors:  S J Robboy; R H Young; W R Welch; G Y Truslow; J Prat; A L Herbst; R E Scully
Journal:  Cancer       Date:  1984-09-01       Impact factor: 6.860

10.  Drug utilization in breast-feeding women. A survey in Oslo.

Authors:  I Matheson; K Kristensen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more
  10 in total

Review 1.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 2.  Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

Authors:  Hanan El Marroun; Tonya White; Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-27       Impact factor: 4.785

Review 3.  Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus.

Authors:  C McGrath; A Buist; T R Norman
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

Review 4.  Antipsychotic use in pregnancy. What are the best treatment options?

Authors:  M Trixler; T Tényi
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 5.  Use of antipsychotics in the management of schizophrenia during pregnancy.

Authors:  Mátyás Trixler; Agnes Gáti; Sándor Fekete; Tamás Tényi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.

Authors:  Megan Galbally; Martien Snellen; Josephine Power
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 7.  Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.

Authors:  Katharine Baratz Dalke; Amy Wenzel; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

8.  Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study.

Authors:  Ragnhild E Brandlistuen; Eivind Ystrom; Sonia Hernandez-Diaz; Svetlana Skurtveit; Randi Selmer; Marte Handal; Hedvig Nordeng
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

Review 9.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.

Authors:  Eline M P Poels; Lisanne Schrijver; Astrid M Kamperman; Manon H J Hillegers; Witte J G Hoogendijk; Steven A Kushner; Sabine J Roza
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-11       Impact factor: 4.785

10.  Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study.

Authors:  Lene Maria Sundbakk; Mollie Wood; Jon Michael Gran; Hedvig Nordeng
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.